Published in Gene Therapy Weekly, March 11th, 2010
"A non-integrating LV may be beneficial in cases in which transient gene expression is desired. Several recent publications outline the development and initial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.